- 2018January 26
GMAX R&D Team is Selected as “Leading Innovation Team”, Zhejiang Province
The GMAX R&D Team on “Diabetes, obesity and pulmonary hypertension” is recently selected as the “Leading Innovation Team of the Zhejiang Province, 2017”.
- 2018June 22
GMAX to Present at the 78th ADA Scientific Sessions
June 22, 2018, Gmax Biopharm, a clinical stage biopharmaceutical company focusing on therapeutic antibody development targeting GPCRs, announced today that it will present the recent clinical progresses of its GLP-1R antibody Glutazumab ...
- 2018June 28
GMAX to Present at the PHA’s 2018 International PH Conference and Scientific Sessions
June 28, 2018, Gmax Biopharm, a clinical stage biopharmaceutical company focusing on therapeutic antibody development targeting GPCRs, announced today that it will present the preclinical and the phase 1 clinical trial results of its ETa antibody Getagozumab ...